Skip to main content
. 2021 Oct 7;5(Suppl 2):e12589. doi: 10.1002/rth2.12589
Plaque characteristic Patients without statins or antithrombotic medication (n = 72) Patients with statins or antithrombotic medication (n = 109)
OR [95% CI] P‐value OR [95% CI] P‐value
IPH presence 5.29 [1.54‐18.06] 0.01* 0.72 [0.30‐1.71] 0.46
Relative IPH volume (%) 1.19 [1.04‐1.35] 0.01* 1.00 [0.94‐1.06] 0.91
LRNC presence 2.45 [0.78‐7.69] 0.13 0.61 [0.26‐1.47] 0.27
Relative LRNC volume (%) 1.12 [1.03‐1.21] 0.01* 0.98 [0.94‐1.02] 0.36
Ulceration presence 5.93 [1.38‐25.37] 0.02* 2.04 [0.81‐5.13] 0.13
Ulceration size 1.70 [0.97‐3.00] 0.07 1.14 [0.77‐1.69] 0.52
Thin or ruptured fibrous cap 1.51 [0.55‐4.13] 0.42 0.75 [0.31‐1.80] 0.51
Calcification presence 0.85 [0.18‐3.95] 0.84 0.99
Relative calcification volume (%) 1.01 [0.92‐1.11] 0.86 1.02 [0.95‐1.10] 0.59